Heartflow director receives stock option grant
Heartflow, Inc. director Jeffrey C. Lightcap received a grant of stock options covering 16,075 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Heartflow, Inc. director Jeffrey C. Lightcap received a grant of stock options covering 16,075 shares of common stock. The options have an exercise price of $32.05 per share and expire on June 16, 2036.
According to the grant terms, the option will vest in full on the earlier of the day prior to Heartflow’s annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to Mr. Lightcap’s continued service through that date. Following this grant, he holds options for 16,075 underlying shares directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 16,075 | $32.05 | $515K |
Footnotes (1)
- F1. The option will vest in full on the earlier of the day prior to Heartflow, Inc.'s annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.
Key Figures
Key Terms
Stock Option financial
Common Stock financial
grant/award acquisition financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Heartflow (HTFL) report for Jeffrey C. Lightcap?
What is the exercise price and expiration date of Jeffrey Lightcap’s Heartflow options?
When do Jeffrey Lightcap’s Heartflow stock options vest?
How many Heartflow derivative securities does Jeffrey Lightcap hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.